INR 51.12
(2.22%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 262.14 Million INR | -26.29% |
2022 | 355.66 Million INR | 57.16% |
2021 | 226.3 Million INR | -3.33% |
2020 | 234.08 Million INR | 52.79% |
2019 | 153.2 Million INR | 24.07% |
2018 | 123.47 Million INR | -4.06% |
2017 | 128.69 Million INR | -4.48% |
2016 | 134.74 Million INR | -1.53% |
2015 | 136.83 Million INR | 16.39% |
2014 | 117.57 Million INR | 13.88% |
2013 | 103.24 Million INR | 66.16% |
2012 | 62.13 Million INR | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 65.48 Million INR | -25.85% |
2023 Q1 | 75.88 Million INR | -1.38% |
2023 Q2 | 82.75 Million INR | 9.06% |
2023 Q4 | 88.31 Million INR | 52.86% |
2023 FY | 262.14 Million INR | -26.29% |
2023 Q3 | 57.77 Million INR | -30.19% |
2022 Q4 | 76.94 Million INR | -26.95% |
2022 Q1 | 67.81 Million INR | 535.99% |
2022 Q2 | 105.57 Million INR | 55.67% |
2022 Q3 | 105.32 Million INR | -0.23% |
2022 FY | 355.66 Million INR | 57.16% |
2021 Q2 | 97.24 Million INR | 90.3% |
2021 Q4 | -15.55 Million INR | -116.63% |
2021 Q1 | 51.1 Million INR | -15.64% |
2021 FY | 226.3 Million INR | -3.33% |
2021 Q3 | 93.51 Million INR | -3.84% |
2020 FY | 234.08 Million INR | 52.79% |
2020 Q2 | 84.07 Million INR | 0.0% |
2020 Q3 | 60.57 Million INR | -27.96% |
2020 Q4 | 60.57 Million INR | 0.0% |
2020 Q1 | 84.07 Million INR | 65.97% |
2019 Q4 | 50.65 Million INR | 0.0% |
2019 FY | 153.2 Million INR | 24.07% |
2019 Q2 | 50.76 Million INR | 0.0% |
2019 Q1 | 50.76 Million INR | 4.22% |
2019 Q3 | 50.65 Million INR | -0.21% |
2018 Q4 | 48.7 Million INR | 0.0% |
2018 FY | 123.47 Million INR | -4.06% |
2018 Q3 | 48.7 Million INR | 23.94% |
2018 Q2 | 39.3 Million INR | 0.0% |
2018 Q1 | 39.3 Million INR | -7.35% |
2017 Q3 | 42.42 Million INR | 1.28% |
2017 Q4 | 42.42 Million INR | 0.0% |
2017 FY | 128.69 Million INR | -4.48% |
2017 Q1 | 41.88 Million INR | 0.0% |
2017 Q2 | 41.88 Million INR | 0.0% |
2016 FY | 134.74 Million INR | -1.53% |
2015 FY | 136.83 Million INR | 16.39% |
2014 FY | 117.57 Million INR | 13.88% |
2013 FY | 103.24 Million INR | 66.16% |
2012 FY | 62.13 Million INR | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Sigachi Industries Limited | 2 Billion INR | 86.908% |
Ind-Swift Limited | 2.17 Billion INR | 87.934% |
Bajaj HealthCare Limited | 1.47 Billion INR | 82.189% |
Sakar Healthcare Limited | 699.58 Million INR | 62.529% |
Aurobindo Pharma Limited | 109.54 Billion INR | 99.761% |
Innova Captab Limited | 3.46 Billion INR | 92.433% |
Divi's Laboratories Limited | 32.44 Billion INR | 99.192% |
AstraZeneca Pharma India Limited | 6.22 Billion INR | 95.787% |
Morepen Laboratories Limited | 6.16 Billion INR | 95.745% |
Mankind Pharma Limited | 42.19 Billion INR | 99.379% |
Sequent Scientific Limited | 2.97 Billion INR | 91.199% |
Wanbury Limited | 1.73 Billion INR | 84.853% |
Laurus Labs Limited | 15.44 Billion INR | 98.303% |
Nectar Lifesciences Limited | 4.82 Billion INR | 94.565% |
Glenmark Life Sciences Limited | 12.43 Billion INR | 97.892% |
Alembic Limited | 1 Billion INR | 73.788% |
Hikal Limited | 5.95 Billion INR | 95.6% |
Alembic Pharmaceuticals Limited | 26.78 Billion INR | 99.021% |
Neuland Laboratories Limited | 8.24 Billion INR | 96.822% |
J. B. Chemicals & Pharmaceuticals Limited | 15.25 Billion INR | 98.282% |
Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 99.622% |
IOL Chemicals and Pharmaceuticals Limited | 4.71 Billion INR | 94.445% |
Themis Medicare Limited | 2.42 Billion INR | 89.168% |
RPG Life Sciences Limited | 2.48 Billion INR | 89.442% |
Zydus Lifesciences Limited | 125.21 Billion INR | 99.791% |
Lupin Limited | 125.09 Billion INR | 99.79% |
Amrutanjan Health Care Limited | 2.09 Billion INR | 87.481% |
Wockhardt Limited | 7.72 Billion INR | 96.604% |
Vaishali Pharma Limited | 90.32 Million INR | -190.23% |
Aarti Pharmalabs Limited | 5.83 Billion INR | 95.505% |
Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | 59.83% |
Jubilant Pharmova Limited | 19.64 Billion INR | 98.665% |
FDC Limited | 6.58 Billion INR | 96.02% |
Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 99.84% |
Kilitch Drugs (India) Limited | 620.47 Million INR | 57.751% |
Eris Lifesciences Limited | 10.42 Billion INR | 97.486% |
Venus Remedies Limited | 2.18 Billion INR | 87.989% |
ZIM Laboratories Limited | 1.26 Billion INR | 79.323% |
Bliss GVS Pharma Limited | 3.69 Billion INR | 92.906% |
Par Drugs and Chemicals Limited | 529.13 Million INR | 50.458% |
Caplin Point Laboratories Limited | 9.2 Billion INR | 97.153% |
Shilpa Medicare Limited | 3.56 Billion INR | 92.64% |
Albert David Limited | 1.4 Billion INR | 81.383% |
Ajanta Pharma Limited | 21.06 Billion INR | 98.755% |
Hester Biosciences Limited | 1.27 Billion INR | 79.418% |
Suven Pharmaceuticals Limited | 4.12 Billion INR | 93.642% |
Solara Active Pharma Sciences Limited | -1.65 Billion INR | 115.831% |
Gufic Biosciences Limited | 4.07 Billion INR | 93.565% |
Windlas Biotech Limited | 1.33 Billion INR | 80.419% |
Procter & Gamble Health Limited | 5.78 Billion INR | 95.466% |
Aarey Drugs & Pharmaceuticals Limited | 113.02 Million INR | -131.926% |
Mangalam Drugs & Organics Limited | 691.19 Million INR | 62.074% |
Granules India Limited | 16.79 Billion INR | 98.44% |
Aarti Drugs Limited | 8.31 Billion INR | 96.848% |
Bal Pharma Limited | 770.19 Million INR | 65.964% |
Alkem Laboratories Limited | 52.29 Billion INR | 99.499% |
Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 99.899% |
Lincoln Pharmaceuticals Limited | 1.88 Billion INR | 86.107% |
Medicamen Biotech Limited | 495.49 Million INR | 47.095% |
Unichem Laboratories Limited | 4.86 Billion INR | 94.612% |
Bafna Pharmaceuticals Limited | 452.15 Million INR | 42.023% |
Biofil Chemicals and Pharmaceuticals Limited | 12.54 Million INR | -1989.629% |
Valiant Laboratories Limited | 138.02 Million INR | -89.92% |
Orchid Pharma Limited | 2.32 Billion INR | 88.702% |
Ind-Swift Laboratories Limited | 4.13 Billion INR | 93.658% |
Ipca Laboratories Limited | 48.58 Billion INR | 99.46% |
Brooks Laboratories Limited | 65.62 Million INR | -299.488% |
Syncom Formulations (India) Limited | 559.5 Million INR | 53.147% |
Piramal Enterprises Limited | 8.04 Billion INR | 96.741% |
Torrent Pharmaceuticals Limited | 46.75 Billion INR | 99.439% |
NATCO Pharma Limited | 25.73 Billion INR | 98.981% |
Suven Life Sciences Limited | -200.79 Million INR | 230.552% |
Krebs Biochemicals & Industries Limited | -108.74 Million INR | 341.059% |
Strides Pharma Science Limited | 14.38 Billion INR | 98.178% |
Indoco Remedies Limited | 8.04 Billion INR | 96.741% |
Alpa Laboratories Limited | 188.89 Million INR | -38.778% |
Lasa Supergenerics Limited | 121.02 Million INR | -116.594% |
Sun Pharma Advanced Research Company Limited | 391.06 Million INR | 32.967% |